Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Bristol-Myers Squibb Co BMY

Bristol-Myers Squibb Company is a biopharmaceutical company engaged in the discovery, development and delivering advanced medicines that help patients prevail over serious diseases. It offers products for various therapeutic classes, which includes oncology, hematology, immunology, cardiovascular and neuroscience. Its pharmaceutical products include chemically synthesized or small molecule... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Current News (NYSE:BMY)

New Four-Year Sotyktu (deucravacitinib) Data Demonstrate Durable Response Rates and Consistent Safety in Moderate-to-Severe Plaque Psoriasis

Business Wire 1 day ago

Bristol Myers Squibb's CAR T Cell Therapy Breyanzi Approved by the U.S. Food and Drug Administration for Relapsed or Refractory Follicular Lymphoma

Business Wire 2 days ago

Bristol Myers Squibb Provides Update on Phase 3 CheckMate -73L Trial

Business Wire 7 days ago

Bristol Myers Squibb to Participate in Upcoming Investor Conferences

Business Wire 11 days ago

European Medicines Agency Validates Bristol Myers Squibb's Application for Opdivo (nivolumab) Plus Yervoy (ipilimumab) for the First-Line Treatment of Adult Patients with Microsatellite...

Business Wire 12 days ago

Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell Collaboration

GlobeNewswire May 1, 2024

Repertoire® Immune Medicines and Bristol Myers Squibb Announce Multi-Year Strategic Collaboration to Develop Tolerizing Vaccines for Autoimmune Diseases

PR Newswire April 29, 2024

CHMP Adopts Positive Opinion Recommending Approval of Bristol Myers Squibb's Opdivo® (nivolumab) in Combination with Cisplatin and Gemcitabine for the First-Line Treatment of Adult Patients with Unresectable or Metastatic Urothelial Carcinoma

Business Wire April 26, 2024

Bristol Myers Squibb Reports First Quarter Financial Results for 2024

Business Wire April 25, 2024

Bullboard Posts (NYSE:BMY)

RE:RE:RE:RE:IVERMICTIN KILLS COVID 19 !

Microscopy Expert: Vials Contain Graphene Oxide, Parasites ... https://forbiddenknowledgetv.net/microscopy-expert...
zeropointenergy - October 16, 2021

RE:RE:RE:IVERMICTIN KILLS COVID 19 !

THE FAUCI INDICTMENT (Video) — SOTN: Alternative News ...   Oct 09, 2021 · THE FAUCI INDICTMENT…...
zeropointenergy - October 16, 2021

RE:RE:RE:IVERMICTIN KILLS COVID 19 !

IS THIS WHY PEOPLE ARE SICK OPP NEEDS TO INVESTIGATE!  Graphene in our foods, not just shots - ugetube.com https://ugetube...
zeropointenergy - October 10, 2021

RE:RE:IVERMICTIN KILLS COVID 19 !

BREAKING NEWS! SPANISH HIGH COURT CONFIRMS THAT … https://ugetube.com/watch/breaking-news-spanish-high-court-confirms... 2021...
zeropointenergy - October 10, 2021

RE:IVERMICTIN KILLS COVID 19 !

Dr. Richard Bartlett on Budesonide, the Silver Bullet ... https://www.thethinkingconservative.com/dr-richard...
zeropointenergy - October 9, 2021

IVERMICTIN KILLS COVID 19 !

 NICE China Reports Zero New Locally Acquired Covid-19 Cases for Fourth Day in a Row  
zeropointenergy - October 9, 2021